by Dorothée van Hooff | May 3, 2017 | Events, News Release
A delegation from Northern Ireland attended the conference in Brussels on the SIMPATHY research programme ‘Polypharmacy and adherence in elderly population’. This conference aimed to showcase the outcome of the EU funded SIMPATHY project.
Third EU Health Programme
Ten organisations from across Europe have come together within the SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) project to address health service provision and sustainable management of medication among the elderly. The project aims to deliver the necessary change in management approaches and develop tools to help manage multi-medication and adherence to prescribed drugs. It is funded by the Third EU Health Programme and aims to stimulate, promote and support innovation across the EU in management of appropriate polypharmacy and adherence in the elderly.
At the final conference good practice was identified and shared like the components required to optimise impact, and new tools were demonstrated to gather evidence on the potential economic impact of improved approaches to polypharmacy. A wide range of professionals and key stakeholders from across Europe were invited to this conference including Ministers of Health and key decision makers. MOIC was represented at the conference by Michael Scott, Glenda Fleming, Cathy Harrison, and Claire Scullin.
‘Active and healthy ageing – Addressing the challenges of multi-medication in Europe’s elderly population’ conference. Organisation by SIMPATHY project, Scottish Government EU Office. Date: 27 April 2017. Location: Scotland House, Rond Point Schuman 6, Brussels.
More information on the conference can be found at simpathy.eu and the SIMPATHY Brussels Workshop Agenda 27 april 2017
Picture: The NI team with Dr Neelam Dhingra (Coordinator of Patient Safety & Quality Improvement Unit – WHO).
by Dorothée van Hooff | May 3, 2017 | News Release
The Catalan delegation visited MOIC on 28th and 29th April under the EIP Reference site twinning scheme. The two-day programme included presentations on the technology solutions LAMPs, Writemed and EPICs, presentations on projects, including GP practice case management, nursing home/intermediate care, and medicines management clinics, in addition to discussions on STEPSelect and tours of the pharmacy department and cardiology ward.
From left: Linden Ashfield, Mireia Massot Mesquida (Pharmacist of Primary Care, Catalan Institute of Health), Ana Clopés Estela (Chief of Pharmaceutical Affairs, Catalan Institute of Health), Ariadna Padullés Zamora (Clinical Pharmacist, Bellvitge Hospital), Anita Hogg, Maria Rosa Morral Parente (Primary Care Director, Catalan Institute of Health), and Michael Scott.
by Dorothée van Hooff | Mar 29, 2017 | News Release
On April 4 representatives of MOIC will visit Hospital Clínic de Barcelona, the university hospital in Barcelona. Glenda Fleming, Claire Scullin, Carmel Darcy, and Linden Ashfield will meet with pharmacy and medicine representatives from Catalonia and Uppsala.
This site visit stems from the work of Project SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly), a consortium of ten partners in eight European Union countries aimed at stimulating improving how medicines are managed in older patients. Catalonia will present its SIMPATHY research programme ‘Innovations in Polypharmacy’.
Catalan Case Study Polypharmacy Programme
by Dorothée van Hooff | Mar 25, 2017 | News Release
Professor Michael Scott visited Oslo and Tromsø 19-25 March 2017 to highlight the Medicines Optimisation unit in Northern Ireland and to discuss collaborations in the whole area of Medicines Optimisation. Professor Scott met with Beate Garcia, Associate Professor Department of Pharmacy, University of Tromsø (Faculty of Health Science Arctic University of Norway), and Professor Anne Gerd Granås, Norwegian PhD School of Pharmacy Oslo.
At the University of Tromsø Profesor Michael Scott gave a seminar on Medicines Optimisation, focused on how, why and when medication safety in hospital is jeopardised, and how this influences patientcare and use of resources in the healthcare services. The Norwegian PhD School of Pharmacy and the Sykehusapotekene HF invited Professor Scott for a series of seminars on medication reviews. At the Oslo University Hospital (Ullevål), and Østfold Hospital (Kalnes) audiences attended the lectures by Professor Scott: ‘From Medicines Management to Medicines Optimisation’, and ‘Medicines Optimisation and clinical pharmacy staff’.
by Dorothée van Hooff | Mar 13, 2017 | News Release
Delia Fernández-Redondo and Emma Bartolomé García (both resident pharmacists, Madrid) visiting NHSCT as part of the International Centres of Excellence in Hospital Pharmacy programme, an initiative developed by the Spanish Society of Hospital Pharmacy (SEFH). Pictured with Linden Ashfield (left) and Professor Michael Scott.
by Dorothée van Hooff | Mar 7, 2017 | Events, News Release
On Tuesday 9 May 2017, Pharmacy Management and UKCPA are going back to Manchester with the second annual conference on Diabetes Medicines Optimisation which has been created by the two organisations.
The Learning Zone will be available for anyone who wishes to present their work in the form of a Poster. In order to do so, please email Jenny Thompson in the first instance to register your interest and receive a pack – jenny.thompson@pharman.co.uk
Booking for delegate places at the website booking page is open with the agenda/Satellite Sessions and registration procedure.
Take the opportunity to review the excellent number of Satellite Sessions and book a place: https://www.pharman.co.uk/events/2017/5/jomo-ukcpa-national-meeting-diabetes
Those satellite presenters who presented in 2016 have been asked to update their presentations and new topics have been incorporated in the light of feedback received. Satellites for this Event:
- Managing Diabetes in the Community – Considerations in older people
- Managing type 1 diabetes in Hospital
- Keeping patients safe: Human factors and a Safety Culture (with practical examples)
- The General Practice Pharmacist – Potential for Diabetes Medicines Optimisation in the Role
- Diabetes and Renal Disease
- The Changing Landscape and the Increased Focus on the Physical Health of the Mental Health Patient (with emphasis on Diabetes)
- Does Motivational Interviewing have a Role in Diabetes?
- How does NICE drive practice in type 2 diabetes?
- Diabetes in the Elderly
- Insulin Safety
- How to Become a System Leader in Diabetes Care
- The Practice Pharmacist’s Contribution to Diabetes Care – The View from the AHSN
- How to Develop Specialist Clinical Pharmacists
- Management of Diabetic Emergencies
- What’s the Risk – Cardiovascular Risk Assessment in Diabetes?
For further information, please contact: Katie Fraser, Senior Executive Assistant Pharmacy Management, Katie.fraser@pharman.co.uk, tel: 01747 829501
JoMO-UKCPA National Meeting: Medicines Optimisation in Diabetes. Location: 9 May 2017, Midland Hotel, Manchester.
Page 25 of 32«2324252627»
